NCT03789890View on ClinicalTrials.gov

Study to Learn More About the Effect of Itraconazole (ITZ) Given Repeatedly by Mouth on the Way How the Study Drug BAY1902607 Given One Time by Mouth Acts in the Human Body of Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

March 4, 2019

Study Completion Date

May 23, 2019

Conditions
Drug Interactions
Interventions
DRUG

BAY1902607

BAY1902607 is administered once orally as tablets on Day 2 of study period 1 and on Day 4 of study period 2.

DRUG

Itraconazole

Itraconazole is administered at a dose of 200 mg once a day (oral solution of 10 mg mL-1) on Day 1 to Day 14 of study period 2.

Trial Locations (1)

13353

CRS Clinical Research Services Berlin GmbH, Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03789890 - Study to Learn More About the Effect of Itraconazole (ITZ) Given Repeatedly by Mouth on the Way How the Study Drug BAY1902607 Given One Time by Mouth Acts in the Human Body of Healthy Male Participants | Biotech Hunter | Biotech Hunter